Exploring the Clinical Profile of SAPHNELO® (anifrolumab-fnia): An Expert Review of the TULIP Pivotal Trials and 4-Year Long-Term Extension Study
Exhibit Hall, Innovation Theater B
Developed and offered by AstraZeneca (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by AstraZeneca (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by GSK (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by UCB (Non-CME)
Exhibit Hall, Innovation Theater B
Independent medical education grant support for this session is provided by Boehringer Ingelheim Pharmaceuticals, Inc., and sponsored by Med Learning Group (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by Pfizer, Inc (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by Johnson & Johnson (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by AbbVie (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by Eli Lilly and Company (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by Bristol Myers Squibb (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by Exagen (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by Kiniksa Pharmaceuticals (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by UCB (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by Cabaletta Bio (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by Sanofi Pharmaceuticals (Non-CME)
Exhibit Hall, Innovation Theater A
Developed and offered by Octapharma (Non-CME)
Exhibit Hall, Innovation Theater B
Developed and offered by GSK
Popular Articles